Assessing seasonal influenza vaccine effectiveness
On 3 December 2015, ECDC hosted a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.
The meeting was attended by representatives of public health and regulatory agencies on national and EU-level, the European Commission, Vaccines Europe, as well as representatives of the I-MOVE project partners and its coordinating partner Epiconcept.
The aim of the meeting was to discuss the design of product-specific and vaccination programme-specific influenza vaccine effectiveness studies in the EU/EEA, and to explore what organisational models would be most useful to support such studies.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
6 Jun 2018 to 8 Jun 2018 - The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
ECDC Expert meeting on non-pharmaceutical countermeasures for Pandemic flu
16 May 2018 to 17 May 2018 - The meeting focused on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.
Acute respiratory pandemics: how to plan for and manage
9 Nov 2017 to 11 Nov 2017 - This practical course will cover outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and will focus around two practical scenarios in which participants will gain experience in managing an acute epidemic. Research during an epidemic and ethical aspects will also be covered.